Science 37, Inc.

Culver City, California 90230

1 studies enrolling now · 4 studies all time

What they study most

Biliary Cancer, Bladder Cancer, Brain Neoplasms, Bronchial Neoplasms, Carcinoma, Bronchogenic, Central Nervous System, Cholangiocarcinoma, Colonic Diseases, Colorectal Neoplasms, Depressive Disorder, Major, Digestive System Diseases, Digestive System Neoplasms

Studies at this site

• Long-term Follow-up of Study Participants Who Received an Allogeneic Chimeric Antigen Receptor T-Cell Product in an Imugene Ltd. Clinical Study — Recruiting now
• My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors — Completed
• A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors — Stopped early
• A Home-based Study Using Mobile Technology to Test Whether BI 1358894 is Effective in People With Depression — Stopped early